The leading web portal for pharmacy resources, news, education and careers May 20, 2012

Pharmacy Choice Newsletter - January 2012

January 5, 2012 Volume 14, Issue 1 Forward to a Friend News Pharmacy Careers Resources Education Business Marketplace Login This newsletter is sponsored by: Industry Headlines 01/04- MNT -Progression-Free Survival Of Patients With Advanced Ovarian Cancer Extended By Targeted Therapy 01/02- Reports from Henry Ford Hospital Describe Recent Advances in Arthritis 12/29- Pfizer's offer of discount Lipitor prompts outcry 12/01- THE $70 BILLION SCAM FDA Resources Generic Drug Approvals Recalls Paragraph IV Patent Certifications News Releases Upcoming Meetings Office of Generic Drugs FDA Drug Shortages Quick Poll Which of the following pairs is not accurate? Xarelto (rivaroxaban) - once daily dosing, CYP450 clearance Viibryd (vilazodone) - serotonin reuptake blocker + 5HT1 receptor agonist Brilinta (ticagrelor) - reversible ADP receptor blocker, taken with low-dose aspirin Arcapta (indacaterol) - Once daily inhaled B-agonist for both COPD and Asthma Dificid (fidaxomicin) - narrow spectrum, bactericidal, C.Diff diarrhea only Can't fill out the poll? GO HERE Hot Pharmacy Jobs Director of Pharmacy Golden Living Pittsburgh, PA Night Pharmacist H-E-B Pharmacy Corpus, TX Outpatient Pharmacy Supervisor Needed!! Rx Pro Health Los Angeles, CA January Disease Focus ADHD: New Treatment Guidelines by Gina D. Moore, PharmD, MBA Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most prevalent childhood conditions, affecting approximately 9.5% or 5.4 million children between 4 and 17 years of age. As medications are often used in the treatment of ADHD, predominantly stimulants, pharmacists play an important role... Read More Featured Article A Review of the New Drugs of 2011 Alan P. Agins, PhD It's hard to believe that 2011 has come and gone. In the world of therapeutics, it was indeed an interesting year for both new drugs and old. As has been the trend for the past few years, while the approval rate of novel, small molecular weight "new molecular entities" continues to decline... Read More Last Month's Poll Approximately how often do you get requests from customers / patients for information related creatine safety and/or effectiveness? Daily - 50.2% Weekly - 6.9% Monthly - 6.9% Annually - 5.2% Never - 30.6% Continuing Education for Pharmacists Enroll now at www.rxschool.com for the latest online Live and Enduring Continuing Education. Inexpensive, easy to access, and excellent content all define the RxSchool Live experience! Live On-line Webinars Fibromyalgia: The Pain is Real Sunday, January 8, 2012 - 7:00 PM ET, 1.0 credit hour LAW! Pharmacy Law and Ethics: Ancient Times to Conscience Clause Tuesday, January 10, 2012 - 12:00 PM ET, 2.0 credit hours What Every Pharmacist Should Know About Childhood Immunizations Wednesday, January 11, 2012 - 7:00 PM ET, 2.0 credit hours Assessing Asthma & Allergic Rhinitis Treatment Options Thursday, January 12, 2012 - 8:00 PM ET, 2.0 credit hours RxSchool is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Featured distance NEW! Drug Diversion and the Pharmacists Corresponding Duty: A Legal Perspective ACPE UPN#: 0372-0000-11-040-H03-P Credits: 2 hour (0.2 CEUs) Release Date: December 2, 2011 Expiration Date: December 2, 2014 Fee: $30.00 Audience: Pharmacists For more information, visit the Course Information Page ©2009 Pharmacy Choice (PC) - All rights reserved. 425 S. Cherry St. Suite 200 | Denver, Colorado 80246 888-682-4415 Important Notice: The information contained in this newsletter is intended as an informational resource only. View our full disclaimer.

Previous Newsletters May 2012 April 2012 March 2012 February 2012 January 2012 December 2011 November 2011 October 2011 September 2011 August 2011 July 2011 June 2011 Advertise Be seen by thousands of industry eyes. Advertise in the Pharmacy Choice Newsletter.